March 20 (Reuters) - Cynata Therapeutics Ltd (CYP) :
- EU REGULATORY & ETHICS APPROVAL FOR PHASE 2 TRIAL OF CYP-001 IN GRAFT VERSUS HOST DISEASE
(([email protected];))
News: CYP Cynata Therapeutics Gets EU Regulatory & Ethics Approval For Phase 2 Trial In Graft...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.020(10.5%) |
Mkt cap ! $37.94M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 21.0¢ | 19.0¢ | $59.64K | 303.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10133 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 12872 | 1 |
View Market Depth
| Last trade - 11.09am 20/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |